nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A2—melanoma	0.888	1	CbGaD
Cefuroxime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00203	0.44	CbGpPWpGaD
Cefuroxime—Local reaction—Bleomycin—melanoma	0.0018	0.018	CcSEcCtD
Cefuroxime—Nephropathy toxic—Bleomycin—melanoma	0.00174	0.0174	CcSEcCtD
Cefuroxime—Drug fever—Docetaxel—melanoma	0.00167	0.0167	CcSEcCtD
Cefuroxime—Nephropathy toxic—Carmustine—melanoma	0.00151	0.0151	CcSEcCtD
Cefuroxime—Digestion impaired—Temozolomide—melanoma	0.00126	0.0126	CcSEcCtD
Cefuroxime—Cholestasis—Temozolomide—melanoma	0.00111	0.0111	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00108	0.0108	CcSEcCtD
Cefuroxime—Injection site pain—Carmustine—melanoma	0.00107	0.0107	CcSEcCtD
Cefuroxime—Eosinophilia—Vemurafenib—melanoma	0.00102	0.0102	CcSEcCtD
Cefuroxime—Ceftibuten—SLC15A2—melanoma	0.000938	0.131	CrCbGaD
Cefuroxime—Infestation—Vemurafenib—melanoma	0.00092	0.0092	CcSEcCtD
Cefuroxime—Infestation NOS—Vemurafenib—melanoma	0.00092	0.0092	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000912	0.00912	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Temozolomide—melanoma	0.000889	0.00889	CcSEcCtD
Cefuroxime—Aplastic anaemia—Dactinomycin—melanoma	0.000873	0.00873	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Temozolomide—melanoma	0.000841	0.00841	CcSEcCtD
Cefuroxime—Vaginal inflammation—Temozolomide—melanoma	0.000841	0.00841	CcSEcCtD
Cefuroxime—Mouth ulceration—Dactinomycin—melanoma	0.00084	0.0084	CcSEcCtD
Cefuroxime—Candida infection—Carmustine—melanoma	0.000831	0.0083	CcSEcCtD
Cefuroxime—Liver disorder—Docetaxel—melanoma	0.00082	0.0082	CcSEcCtD
Cefuroxime—Haemoglobin decreased—Docetaxel—melanoma	0.000812	0.00812	CcSEcCtD
Cefuroxime—Candida infection—Temozolomide—melanoma	0.000803	0.00803	CcSEcCtD
Cefuroxime—Vaginal infection—Temozolomide—melanoma	0.000794	0.00794	CcSEcCtD
Cefuroxime—Aplastic anaemia—Temozolomide—melanoma	0.000789	0.00789	CcSEcCtD
Cefuroxime—Erythema multiforme—Vemurafenib—melanoma	0.000781	0.00781	CcSEcCtD
Cefuroxime—Cefepime—SLC15A2—melanoma	0.000773	0.108	CrCbGaD
Cefuroxime—Angiopathy—Vemurafenib—melanoma	0.000749	0.00749	CcSEcCtD
Cefuroxime—Chills—Vemurafenib—melanoma	0.000741	0.00741	CcSEcCtD
Cefuroxime—Thrombophlebitis—Carmustine—melanoma	0.000729	0.00729	CcSEcCtD
Cefuroxime—Erythema—Vemurafenib—melanoma	0.000719	0.00719	CcSEcCtD
Cefuroxime—Thrombophlebitis—Temozolomide—melanoma	0.000705	0.00705	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000702	0.00702	CcSEcCtD
Cefuroxime—Thirst—Temozolomide—melanoma	0.000641	0.00641	CcSEcCtD
Cefuroxime—Cough—Vemurafenib—melanoma	0.000627	0.00627	CcSEcCtD
Cefuroxime—Arthralgia—Vemurafenib—melanoma	0.000612	0.00612	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000608	0.00608	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000608	0.00607	CcSEcCtD
Cefuroxime—Cefixime—SLC15A2—melanoma	0.000605	0.0844	CrCbGaD
Cefuroxime—Pancytopenia—Bleomycin—melanoma	0.000594	0.00594	CcSEcCtD
Cefuroxime—Blood bilirubin increased—Docetaxel—melanoma	0.000591	0.00591	CcSEcCtD
Cefuroxime—Anaphylactic shock—Vemurafenib—melanoma	0.000587	0.00587	CcSEcCtD
Cefuroxime—Skin disorder—Vemurafenib—melanoma	0.00057	0.0057	CcSEcCtD
Cefuroxime—Ceftazidime—SLC15A2—melanoma	0.000568	0.0794	CrCbGaD
Cefuroxime—Phosphatase alkaline increased—Docetaxel—melanoma	0.000559	0.00559	CcSEcCtD
Cefuroxime—Cefdinir—SLC15A2—melanoma	0.000558	0.0779	CrCbGaD
Cefuroxime—Pancytopenia—Dactinomycin—melanoma	0.000554	0.00554	CcSEcCtD
Cefuroxime—Cefaclor—SLC15A2—melanoma	0.000553	0.0772	CrCbGaD
Cefuroxime—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00055	0.00549	CcSEcCtD
Cefuroxime—Neutropenia—Dactinomycin—melanoma	0.000545	0.00545	CcSEcCtD
Cefuroxime—Stomatitis—Bleomycin—melanoma	0.000543	0.00543	CcSEcCtD
Cefuroxime—Colitis—Docetaxel—melanoma	0.000537	0.00537	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000535	0.00535	CcSEcCtD
Cefuroxime—Candida infection—Docetaxel—melanoma	0.000534	0.00534	CcSEcCtD
Cefuroxime—Cefradine—SLC15A2—melanoma	0.00053	0.074	CrCbGaD
Cefuroxime—Pancytopenia—Carmustine—melanoma	0.000518	0.00518	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000515	0.00515	CcSEcCtD
Cefuroxime—Neutropenia—Carmustine—melanoma	0.00051	0.0051	CcSEcCtD
Cefuroxime—Decreased appetite—Vemurafenib—melanoma	0.00051	0.0051	CcSEcCtD
Cefuroxime—Bronchitis—Temozolomide—melanoma	0.000507	0.00507	CcSEcCtD
Cefuroxime—Stomatitis—Dactinomycin—melanoma	0.000507	0.00507	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Vemurafenib—melanoma	0.000507	0.00507	CcSEcCtD
Cefuroxime—Haemoglobin—Bleomycin—melanoma	0.000503	0.00503	CcSEcCtD
Cefuroxime—Cefadroxil—SLC15A2—melanoma	0.000501	0.07	CrCbGaD
Cefuroxime—Pancytopenia—Temozolomide—melanoma	0.000501	0.00501	CcSEcCtD
Cefuroxime—Haemorrhage—Bleomycin—melanoma	0.0005	0.005	CcSEcCtD
Cefuroxime—Neutropenia—Temozolomide—melanoma	0.000493	0.00493	CcSEcCtD
Cefuroxime—Dysuria—Temozolomide—melanoma	0.000493	0.00493	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Temozolomide—melanoma	0.00049	0.0049	CcSEcCtD
Cefuroxime—Agranulocytosis—Dactinomycin—melanoma	0.000485	0.00485	CcSEcCtD
Cefuroxime—Renal failure—Carmustine—melanoma	0.000478	0.00478	CcSEcCtD
Cefuroxime—Stomatitis—Carmustine—melanoma	0.000474	0.00474	CcSEcCtD
Cefuroxime—Urinary tract infection—Carmustine—melanoma	0.000473	0.00473	CcSEcCtD
Cefuroxime—Infestation NOS—Temozolomide—melanoma	0.00047	0.0047	CcSEcCtD
Cefuroxime—Infestation—Temozolomide—melanoma	0.00047	0.0047	CcSEcCtD
Cefuroxime—Thrombophlebitis—Docetaxel—melanoma	0.000469	0.00469	CcSEcCtD
Cefuroxime—Hepatitis—Dactinomycin—melanoma	0.000467	0.00467	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000467	0.00467	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000466	0.00466	CcSEcCtD
Cefuroxime—Body temperature increased—Vemurafenib—melanoma	0.000464	0.00464	CcSEcCtD
Cefuroxime—Stomatitis—Temozolomide—melanoma	0.000458	0.00458	CcSEcCtD
Cefuroxime—Urinary tract infection—Temozolomide—melanoma	0.000457	0.00457	CcSEcCtD
Cefuroxime—Chills—Bleomycin—melanoma	0.000449	0.00449	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Temozolomide—melanoma	0.000445	0.00445	CcSEcCtD
Cefuroxime—Erythema multiforme—Dactinomycin—melanoma	0.000441	0.00441	CcSEcCtD
Cefuroxime—Sinusitis—Temozolomide—melanoma	0.000441	0.00441	CcSEcCtD
Cefuroxime—Haemoglobin—Carmustine—melanoma	0.000439	0.00439	CcSEcCtD
Cefuroxime—Cefotaxime—SLC15A2—melanoma	0.000437	0.0611	CrCbGaD
Cefuroxime—Haemorrhage—Carmustine—melanoma	0.000437	0.00437	CcSEcCtD
Cefuroxime—Erythema—Bleomycin—melanoma	0.000436	0.00436	CcSEcCtD
Cefuroxime—Hypersensitivity—Vemurafenib—melanoma	0.000432	0.00432	CcSEcCtD
Cefuroxime—Ceftriaxone—SLC15A2—melanoma	0.000431	0.0602	CrCbGaD
Cefuroxime—Renal impairment—Docetaxel—melanoma	0.000426	0.00426	CcSEcCtD
Cefuroxime—Haemoglobin—Temozolomide—melanoma	0.000424	0.00424	CcSEcCtD
Cefuroxime—Haemorrhage—Temozolomide—melanoma	0.000422	0.00422	CcSEcCtD
Cefuroxime—Hepatitis—Temozolomide—melanoma	0.000422	0.00422	CcSEcCtD
Cefuroxime—Chills—Dactinomycin—melanoma	0.000419	0.00419	CcSEcCtD
Cefuroxime—Urinary tract disorder—Temozolomide—melanoma	0.000417	0.00417	CcSEcCtD
Cefuroxime—Pruritus—Vemurafenib—melanoma	0.000415	0.00415	CcSEcCtD
Cefuroxime—Urethral disorder—Temozolomide—melanoma	0.000414	0.00414	CcSEcCtD
Cefuroxime—Erythema—Dactinomycin—melanoma	0.000406	0.00406	CcSEcCtD
Cefuroxime—Diarrhoea—Vemurafenib—melanoma	0.000402	0.00401	CcSEcCtD
Cefuroxime—Erythema multiforme—Temozolomide—melanoma	0.000399	0.00399	CcSEcCtD
Cefuroxime—Leukopenia—Bleomycin—melanoma	0.00039	0.0039	CcSEcCtD
Cefuroxime—Dizziness—Vemurafenib—melanoma	0.000388	0.00388	CcSEcCtD
Cefuroxime—Angiopathy—Temozolomide—melanoma	0.000383	0.00383	CcSEcCtD
Cefuroxime—Immune system disorder—Temozolomide—melanoma	0.000381	0.00381	CcSEcCtD
Cefuroxime—Erythema—Carmustine—melanoma	0.00038	0.0038	CcSEcCtD
Cefuroxime—Cough—Bleomycin—melanoma	0.00038	0.0038	CcSEcCtD
Cefuroxime—Chills—Temozolomide—melanoma	0.000379	0.00379	CcSEcCtD
Cefuroxime—Cefalotin—SLC15A2—melanoma	0.000377	0.0527	CrCbGaD
Cefuroxime—Vomiting—Vemurafenib—melanoma	0.000373	0.00373	CcSEcCtD
Cefuroxime—Chest pain—Bleomycin—melanoma	0.000371	0.00371	CcSEcCtD
Cefuroxime—Rash—Vemurafenib—melanoma	0.00037	0.0037	CcSEcCtD
Cefuroxime—Dermatitis—Vemurafenib—melanoma	0.00037	0.0037	CcSEcCtD
Cefuroxime—Headache—Vemurafenib—melanoma	0.000368	0.00368	CcSEcCtD
Cefuroxime—Erythema—Temozolomide—melanoma	0.000367	0.00367	CcSEcCtD
Cefuroxime—Cramp muscle—Docetaxel—melanoma	0.000365	0.00365	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000365	0.00365	CcSEcCtD
Cefuroxime—Leukopenia—Dactinomycin—melanoma	0.000364	0.00364	CcSEcCtD
Cefuroxime—Anaphylactic shock—Bleomycin—melanoma	0.000356	0.00356	CcSEcCtD
Cefuroxime—Agitation—Carmustine—melanoma	0.000349	0.00349	CcSEcCtD
Cefuroxime—Nausea—Vemurafenib—melanoma	0.000349	0.00349	CcSEcCtD
Cefuroxime—Thrombocytopenia—Bleomycin—melanoma	0.000348	0.00348	CcSEcCtD
Cefuroxime—Cephalexin—SLC15A2—melanoma	0.000343	0.0479	CrCbGaD
Cefuroxime—Leukopenia—Carmustine—melanoma	0.00034	0.0034	CcSEcCtD
Cefuroxime—Anorexia—Bleomycin—melanoma	0.000339	0.00339	CcSEcCtD
Cefuroxime—Agitation—Temozolomide—melanoma	0.000338	0.00338	CcSEcCtD
Cefuroxime—Angioedema—Temozolomide—melanoma	0.000336	0.00336	CcSEcCtD
Cefuroxime—Pancytopenia—Docetaxel—melanoma	0.000333	0.00333	CcSEcCtD
Cefuroxime—Convulsion—Carmustine—melanoma	0.000329	0.00329	CcSEcCtD
Cefuroxime—Leukopenia—Temozolomide—melanoma	0.000329	0.00329	CcSEcCtD
Cefuroxime—Neutropenia—Docetaxel—melanoma	0.000328	0.00328	CcSEcCtD
Cefuroxime—Palpitations—Temozolomide—melanoma	0.000325	0.00325	CcSEcCtD
Cefuroxime—Thrombocytopenia—Dactinomycin—melanoma	0.000325	0.00325	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Bleomycin—melanoma	0.000324	0.00324	CcSEcCtD
Cefuroxime—Chest pain—Carmustine—melanoma	0.000324	0.00324	CcSEcCtD
Cefuroxime—Cough—Temozolomide—melanoma	0.000321	0.00321	CcSEcCtD
Cefuroxime—Convulsion—Temozolomide—melanoma	0.000318	0.00318	CcSEcCtD
Cefuroxime—Dyspnoea—Bleomycin—melanoma	0.000317	0.00317	CcSEcCtD
Cefuroxime—Anorexia—Dactinomycin—melanoma	0.000316	0.00316	CcSEcCtD
Cefuroxime—Arthralgia—Temozolomide—melanoma	0.000313	0.00313	CcSEcCtD
Cefuroxime—Infestation NOS—Docetaxel—melanoma	0.000313	0.00313	CcSEcCtD
Cefuroxime—Infestation—Docetaxel—melanoma	0.000313	0.00313	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000311	0.00311	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00031	0.0031	CcSEcCtD
Cefuroxime—Decreased appetite—Bleomycin—melanoma	0.000309	0.00309	CcSEcCtD
Cefuroxime—Renal failure—Docetaxel—melanoma	0.000307	0.00307	CcSEcCtD
Cefuroxime—Jaundice—Docetaxel—melanoma	0.000305	0.00305	CcSEcCtD
Cefuroxime—Stomatitis—Docetaxel—melanoma	0.000305	0.00305	CcSEcCtD
Cefuroxime—Pain—Bleomycin—melanoma	0.000304	0.00304	CcSEcCtD
Cefuroxime—Thrombocytopenia—Carmustine—melanoma	0.000304	0.00304	CcSEcCtD
Cefuroxime—Tachycardia—Carmustine—melanoma	0.000303	0.00303	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000302	0.00302	CcSEcCtD
Cefuroxime—Anaphylactic shock—Temozolomide—melanoma	0.0003	0.003	CcSEcCtD
Cefuroxime—Anorexia—Carmustine—melanoma	0.000296	0.00296	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Docetaxel—melanoma	0.000296	0.00296	CcSEcCtD
Cefuroxime—Thrombocytopenia—Temozolomide—melanoma	0.000294	0.00294	CcSEcCtD
Cefuroxime—Agranulocytosis—Docetaxel—melanoma	0.000292	0.00292	CcSEcCtD
Cefuroxime—Skin disorder—Temozolomide—melanoma	0.000291	0.00291	CcSEcCtD
Cefuroxime—Hyperhidrosis—Temozolomide—melanoma	0.00029	0.0029	CcSEcCtD
Cefuroxime—Decreased appetite—Dactinomycin—melanoma	0.000288	0.00288	CcSEcCtD
Cefuroxime—Anorexia—Temozolomide—melanoma	0.000286	0.00286	CcSEcCtD
Cefuroxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000284	0.0614	CbGpPWpGaD
Cefuroxime—Pain—Dactinomycin—melanoma	0.000284	0.00284	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Carmustine—melanoma	0.000283	0.00283	CcSEcCtD
Cefuroxime—Urticaria—Bleomycin—melanoma	0.000282	0.00282	CcSEcCtD
Cefuroxime—Haemoglobin—Docetaxel—melanoma	0.000282	0.00282	CcSEcCtD
Cefuroxime—Body temperature increased—Bleomycin—melanoma	0.000281	0.00281	CcSEcCtD
Cefuroxime—Haemorrhage—Docetaxel—melanoma	0.000281	0.00281	CcSEcCtD
Cefuroxime—Hepatitis—Docetaxel—melanoma	0.000281	0.00281	CcSEcCtD
Cefuroxime—Urinary tract disorder—Docetaxel—melanoma	0.000277	0.00277	CcSEcCtD
Cefuroxime—Dyspnoea—Carmustine—melanoma	0.000277	0.00277	CcSEcCtD
Cefuroxime—Somnolence—Carmustine—melanoma	0.000276	0.00276	CcSEcCtD
Cefuroxime—Urethral disorder—Docetaxel—melanoma	0.000275	0.00275	CcSEcCtD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000274	0.0592	CbGpPWpGaD
Cefuroxime—Musculoskeletal discomfort—Temozolomide—melanoma	0.000273	0.00273	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dactinomycin—melanoma	0.000271	0.00271	CcSEcCtD
Cefuroxime—Decreased appetite—Carmustine—melanoma	0.00027	0.0027	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Carmustine—melanoma	0.000268	0.00268	CcSEcCtD
Cefuroxime—Dyspnoea—Temozolomide—melanoma	0.000267	0.00267	CcSEcCtD
Cefuroxime—Somnolence—Temozolomide—melanoma	0.000267	0.00267	CcSEcCtD
Cefuroxime—Erythema multiforme—Docetaxel—melanoma	0.000265	0.00265	CcSEcCtD
Cefuroxime—Pain—Carmustine—melanoma	0.000265	0.00265	CcSEcCtD
Cefuroxime—Dyspepsia—Temozolomide—melanoma	0.000264	0.00264	CcSEcCtD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000263	0.057	CbGpPWpGaD
Cefuroxime—Body temperature increased—Dactinomycin—melanoma	0.000262	0.00262	CcSEcCtD
Cefuroxime—Abdominal pain—Dactinomycin—melanoma	0.000262	0.00262	CcSEcCtD
Cefuroxime—Hypersensitivity—Bleomycin—melanoma	0.000262	0.00262	CcSEcCtD
Cefuroxime—Decreased appetite—Temozolomide—melanoma	0.000261	0.00261	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Temozolomide—melanoma	0.000259	0.00259	CcSEcCtD
Cefuroxime—Pain—Temozolomide—melanoma	0.000256	0.00256	CcSEcCtD
Cefuroxime—Angiopathy—Docetaxel—melanoma	0.000255	0.00255	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Carmustine—melanoma	0.000254	0.00254	CcSEcCtD
Cefuroxime—Immune system disorder—Docetaxel—melanoma	0.000254	0.00254	CcSEcCtD
Cefuroxime—Chills—Docetaxel—melanoma	0.000252	0.00252	CcSEcCtD
Cefuroxime—Pruritus—Bleomycin—melanoma	0.000252	0.00252	CcSEcCtD
Cefuroxime—Abdominal pain—Carmustine—melanoma	0.000245	0.00245	CcSEcCtD
Cefuroxime—Body temperature increased—Carmustine—melanoma	0.000245	0.00245	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Temozolomide—melanoma	0.000245	0.00245	CcSEcCtD
Cefuroxime—Erythema—Docetaxel—melanoma	0.000244	0.00244	CcSEcCtD
Cefuroxime—Hypersensitivity—Dactinomycin—melanoma	0.000244	0.00244	CcSEcCtD
Cefuroxime—Urticaria—Temozolomide—melanoma	0.000238	0.00238	CcSEcCtD
Cefuroxime—Body temperature increased—Temozolomide—melanoma	0.000237	0.00237	CcSEcCtD
Cefuroxime—Abdominal pain—Temozolomide—melanoma	0.000237	0.00237	CcSEcCtD
Cefuroxime—Muscle spasms—Docetaxel—melanoma	0.000235	0.00235	CcSEcCtD
Cefuroxime—Hypersensitivity—Carmustine—melanoma	0.000229	0.00229	CcSEcCtD
Cefuroxime—Diarrhoea—Dactinomycin—melanoma	0.000227	0.00227	CcSEcCtD
Cefuroxime—Vomiting—Bleomycin—melanoma	0.000226	0.00226	CcSEcCtD
Cefuroxime—Rash—Bleomycin—melanoma	0.000224	0.00224	CcSEcCtD
Cefuroxime—Dermatitis—Bleomycin—melanoma	0.000224	0.00224	CcSEcCtD
Cefuroxime—Hypersensitivity—Temozolomide—melanoma	0.000221	0.00221	CcSEcCtD
Cefuroxime—Leukopenia—Docetaxel—melanoma	0.000219	0.00219	CcSEcCtD
Cefuroxime—Palpitations—Docetaxel—melanoma	0.000216	0.00216	CcSEcCtD
Cefuroxime—Cough—Docetaxel—melanoma	0.000213	0.00213	CcSEcCtD
Cefuroxime—Diarrhoea—Carmustine—melanoma	0.000212	0.00212	CcSEcCtD
Cefuroxime—Pruritus—Temozolomide—melanoma	0.000212	0.00212	CcSEcCtD
Cefuroxime—Convulsion—Docetaxel—melanoma	0.000212	0.00212	CcSEcCtD
Cefuroxime—Nausea—Bleomycin—melanoma	0.000211	0.00211	CcSEcCtD
Cefuroxime—Vomiting—Dactinomycin—melanoma	0.000211	0.00211	CcSEcCtD
Cefuroxime—Rash—Dactinomycin—melanoma	0.000209	0.00209	CcSEcCtD
Cefuroxime—Arthralgia—Docetaxel—melanoma	0.000208	0.00208	CcSEcCtD
Cefuroxime—Chest pain—Docetaxel—melanoma	0.000208	0.00208	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000207	0.00207	CcSEcCtD
Cefuroxime—Dizziness—Carmustine—melanoma	0.000205	0.00205	CcSEcCtD
Cefuroxime—Diarrhoea—Temozolomide—melanoma	0.000205	0.00205	CcSEcCtD
Cefuroxime—Cefonicid—ALB—melanoma	0.000202	0.0282	CrCbGaD
Cefuroxime—Anaphylactic shock—Docetaxel—melanoma	0.000199	0.00199	CcSEcCtD
Cefuroxime—Dizziness—Temozolomide—melanoma	0.000198	0.00198	CcSEcCtD
Cefuroxime—Vomiting—Carmustine—melanoma	0.000197	0.00197	CcSEcCtD
Cefuroxime—Nausea—Dactinomycin—melanoma	0.000197	0.00197	CcSEcCtD
Cefuroxime—Rash—Carmustine—melanoma	0.000196	0.00196	CcSEcCtD
Cefuroxime—Dermatitis—Carmustine—melanoma	0.000196	0.00195	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—melanoma	0.000195	0.00195	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—melanoma	0.000195	0.00195	CcSEcCtD
Cefuroxime—Headache—Carmustine—melanoma	0.000194	0.00194	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—melanoma	0.000194	0.00194	CcSEcCtD
Cefuroxime—Vomiting—Temozolomide—melanoma	0.000191	0.00191	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—melanoma	0.00019	0.0019	CcSEcCtD
Cefuroxime—Rash—Temozolomide—melanoma	0.000189	0.00189	CcSEcCtD
Cefuroxime—Dermatitis—Temozolomide—melanoma	0.000189	0.00189	CcSEcCtD
Cefuroxime—Headache—Temozolomide—melanoma	0.000188	0.00188	CcSEcCtD
Cefuroxime—Nausea—Carmustine—melanoma	0.000184	0.00184	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—melanoma	0.000182	0.00182	CcSEcCtD
Cefuroxime—Nausea—Temozolomide—melanoma	0.000178	0.00178	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—melanoma	0.000178	0.00178	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—melanoma	0.000177	0.00177	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—melanoma	0.000176	0.00176	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—melanoma	0.000173	0.00173	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—melanoma	0.000172	0.00172	CcSEcCtD
Cefuroxime—Pain—Docetaxel—melanoma	0.000171	0.00171	CcSEcCtD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000167	0.0362	CbGpPWpGaD
Cefuroxime—Gastrointestinal pain—Docetaxel—melanoma	0.000163	0.00163	CcSEcCtD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000161	0.0349	CbGpPWpGaD
Cefuroxime—Body temperature increased—Docetaxel—melanoma	0.000158	0.00158	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—melanoma	0.000158	0.00158	CcSEcCtD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000155	0.0336	CbGpPWpGaD
Cefuroxime—Hypersensitivity—Docetaxel—melanoma	0.000147	0.00147	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—melanoma	0.000141	0.00141	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—melanoma	0.000136	0.00136	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—melanoma	0.000132	0.00132	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—melanoma	0.000127	0.00127	CcSEcCtD
Cefuroxime—Rash—Docetaxel—melanoma	0.000126	0.00126	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—melanoma	0.000126	0.00126	CcSEcCtD
Cefuroxime—Headache—Docetaxel—melanoma	0.000125	0.00125	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—melanoma	0.000118	0.00118	CcSEcCtD
Cefuroxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000118	0.0255	CbGpPWpGaD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000109	0.0237	CbGpPWpGaD
Cefuroxime—Cefazolin—ALB—melanoma	9.78e-05	0.0137	CrCbGaD
Cefuroxime—Ceftriaxone—ALB—melanoma	9.27e-05	0.0129	CrCbGaD
Cefuroxime—Cefalotin—ALB—melanoma	8.12e-05	0.0113	CrCbGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	7.51e-05	0.0162	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.47e-05	0.0162	CbGpPWpGaD
Cefuroxime—Cephalexin—ALB—melanoma	7.38e-05	0.0103	CrCbGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	7.2e-05	0.0156	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	6.97e-05	0.0151	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	6.94e-05	0.015	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	6.93e-05	0.015	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.78e-05	0.0147	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	6.44e-05	0.0139	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.3e-05	0.0136	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	5.2e-05	0.0113	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	4.83e-05	0.0104	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	3.8e-05	0.00821	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	3.66e-05	0.00792	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	3.52e-05	0.00762	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	3.45e-05	0.00746	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	3.2e-05	0.00692	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.1e-05	0.00671	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.88e-05	0.00623	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.58e-05	0.00341	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	1.48e-05	0.0032	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.46e-05	0.00317	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	1.37e-05	0.00297	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.2e-05	0.0026	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	1.12e-05	0.00241	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	7.52e-06	0.00163	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	6.98e-06	0.00151	CbGpPWpGaD
